These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17822918)

  • 1. Neurochemical and neurobehavioral effects of ganstigmine (CHF2819), a novel acetylcholinesterase inhibitor, in rat prefrontal cortex: an in vivo study.
    Trabace L; Cassano T; Colaianna M; Castrignanò S; Giustino A; Amoroso S; Steardo L; Cuomo V
    Pharmacol Res; 2007 Oct; 56(4):288-94. PubMed ID: 17822918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and neurobehavioral profile of CHF2819, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease.
    Trabace L; Cassano T; Steardo L; Pietra C; Villetti G; Kendrick KM; Cuomo V
    J Pharmacol Exp Ther; 2000 Jul; 294(1):187-94. PubMed ID: 10871311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ginkgo biloba leaf extract (EGb 761®) and its specific acylated flavonol constituents increase dopamine and acetylcholine levels in the rat medial prefrontal cortex: possible implications for the cognitive enhancing properties of EGb 761®.
    Kehr J; Yoshitake S; Ijiri S; Koch E; Nöldner M; Yoshitake T
    Int Psychogeriatr; 2012 Aug; 24 Suppl 1():S25-34. PubMed ID: 22784425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganstigmine and donepezil improve neurodegeneration in AD11 antinerve growth factor transgenic mice.
    Capsoni S; Giannotta S; Stebel M; Garcia AA; De Rosa R; Villetti G; Imbimbo BP; Pietra C; Cattaneo A
    Am J Alzheimers Dis Other Demen; 2004; 19(3):153-60. PubMed ID: 15214201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural determinants of Torpedo californica acetylcholinesterase inhibition by the novel and orally active carbamate based anti-alzheimer drug ganstigmine (CHF-2819).
    Bartolucci C; Siotto M; Ghidini E; Amari G; Bolzoni PT; Racchi M; Villetti G; Delcanale M; Lamba D
    J Med Chem; 2006 Aug; 49(17):5051-8. PubMed ID: 16913695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of subchronic exposure to styrene on the extracellular and tissue levels of dopamine, serotonin and their metabolites in rat brain.
    Gagnaire F; Chalansonnet M; Carabin N; Micillino JC
    Arch Toxicol; 2006 Oct; 80(10):703-12. PubMed ID: 16518643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the effect of ganstigmine (CHF2819) on amyloid precursor protein metabolism in SH-SY5Y neuroblastoma cells.
    Mazzucchelli M; Porrello E; Villetti G; Pietra C; Govoni S; Racchi M
    J Neural Transm (Vienna); 2003 Aug; 110(8):935-47. PubMed ID: 12898348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative studies of huperzine A, donepezil, and rivastigmine on brain acetylcholine, dopamine, norepinephrine, and 5-hydroxytryptamine levels in freely-moving rats.
    Liang YQ; Tang XC
    Acta Pharmacol Sin; 2006 Sep; 27(9):1127-36. PubMed ID: 16923332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHF2819: pharmacological profile of a novel acetylcholinesterase inhibitor.
    Trabace L; Cassano T; Loverre A; Steardo L; Cuomo V
    CNS Drug Rev; 2002; 8(1):53-69. PubMed ID: 12070526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of MF-268, a new cholinesterase inhibitor, on acetylcholine and biogenic amines in rat cortex.
    Zhu XD; Cuadra G; Brufani M; Maggi T; Pagella PG; Williams E; Giacobini E
    J Neurosci Res; 1996 Jan; 43(1):120-6. PubMed ID: 8838583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study.
    Shearman E; Rossi S; Szasz B; Juranyi Z; Fallon S; Pomara N; Sershen H; Lajtha A
    Brain Res Bull; 2006 Mar; 69(2):204-13. PubMed ID: 16533671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo neurochemical effects of the acetylcholinesterase inhibitor ENA713 in rat hippocampus.
    Trabace L; Coluccia A; Gaetani S; Tattoli M; Cagiano R; Pietra C; Kendrick KM; Cuomo V
    Brain Res; 2000 May; 865(2):268-71. PubMed ID: 10821930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of tachykinin NK1 receptors attenuates stress-induced rise of extracellular noradrenaline and dopamine in the rat and gerbil medial prefrontal cortex.
    Renoldi G; Invernizzi RW
    J Neurosci Res; 2006 Oct; 84(5):961-8. PubMed ID: 16862563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological activity and safety profile of P10358, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease.
    Smith CP; Bores GM; Petko W; Li M; Selk DE; Rush DK; Camacho F; Winslow JT; Fishkin R; Cunningham DM; Brooks KM; Roehr J; Hartman HB; Davis L; Vargas HM
    J Pharmacol Exp Ther; 1997 Feb; 280(2):710-20. PubMed ID: 9023283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-sensitive liquid chromatographic method for determination of neuronal release of serotonin, noradrenaline and dopamine monitored by microdialysis in the rat prefrontal cortex.
    Yoshitake T; Yoshitake S; Fujino K; Nohta H; Yamaguchi M; Kehr J
    J Neurosci Methods; 2004 Dec; 140(1-2):163-8. PubMed ID: 15589346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice.
    Koda K; Ago Y; Cong Y; Kita Y; Takuma K; Matsuda T
    J Neurochem; 2010 Jul; 114(1):259-70. PubMed ID: 20403082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of corticotropin releasing factor receptor 1 antagonist on extracellular norepinephrine, dopamine and serotonin in hippocampus and prefrontal cortex of rats in vivo.
    Isogawa K; Akiyoshi J; Hikichi T; Yamamoto Y; Tsutsumi T; Nagayama H
    Neuropeptides; 2000; 34(3-4):234-9. PubMed ID: 11021986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinesterase inhibitor effects on neurotransmitters in rat cortex in vivo.
    Cuadra G; Summers K; Giacobini E
    J Pharmacol Exp Ther; 1994 Jul; 270(1):277-84. PubMed ID: 7913496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-by-second measurement of acetylcholine release in prefrontal cortex.
    Bruno JP; Gash C; Martin B; Zmarowski A; Pomerleau F; Burmeister J; Huettl P; Gerhardt GA
    Eur J Neurosci; 2006 Nov; 24(10):2749-57. PubMed ID: 17156201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-release of noradrenaline and dopamine in the prefrontal cortex after acute morphine and during morphine withdrawal.
    Devoto P; Flore G; Pira L; Diana M; Gessa GL
    Psychopharmacology (Berl); 2002 Mar; 160(2):220-4. PubMed ID: 11875641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.